Alastair Garfield
CIK 2027261 · View on SEC EDGAR ↗
First SEC filing: Feb. 13, 2026 · Latest: Feb. 13, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 13, 2026 | RYTM | S 10b5-1 | 2,007 | $116.11 | $233,033 | 8,051 Direct | -19.95% | Disposed | -5.4% (price as of 2026-08-21) |
| Aug. 13, 2026 | RYTM | S 10b5-1 | 1,556 | $117.08 | $182,176 | 6,495 Direct | -19.33% | Disposed | -6.2% (price as of 2026-08-21) |
| Aug. 13, 2026 | RYTM | S 10b5-1 | 3,400 | $118.28 | $402,152 | 3,095 Direct | -52.35% | Disposed | -7.2% (price as of 2026-08-21) |
| Aug. 13, 2026 | RYTM | S 10b5-1 | 800 | $119.17 | $95,336 | 2,295 Direct | -25.85% | Disposed | -7.9% (price as of 2026-08-21) |
| July 2, 2025 | RYTM | S 10b5-1 | 1,313 | $64.81 | $85,096 | 3,132 Direct | -29.54% | Disposed | 69.4% (price as of 2026-08-21) |
| July 2, 2025 | RYTM | S 10b5-1 | 6 | $64.60 | $388 | 3,126 Direct | -0.19% | Disposed | 70.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 1, 2026 | RYTM | Restricted Stock Units | Common Stock (4,445) | — | — | 4,445 | Disposed |
| Feb. 11, 2026 | RYTM | Restricted Stock Units | Common Stock (16,650) | — | — | 16,650 | Acquired |
| Feb. 11, 2026 | RYTM | Stock Options (Right to Buy) | Common Stock (25,000) | $98.47 | Feb. 10, 2036 | 25,000 | Acquired |
| Feb. 1, 2026 | RYTM | Restricted Stock Units | Common Stock (6,663) | — | — | 6,663 | Disposed |
| July 1, 2025 | RYTM | Restricted Stock Units | Common Stock (4,445) | — | — | 4,445 | Disposed |
| Feb. 14, 2025 | RYTM | Stock Options (Right to Buy) | Common Stock (40,000) | $56.69 | Feb. 13, 2035 | 40,000 | Acquired |
| Feb. 14, 2025 | RYTM | Restricted Stock Units | Common Stock (26,650) | — | — | 26,650 | Acquired |
| July 8, 2024 | RYTM | Restricted Stock Units | Common Stock (17,778) | — | — | 17,778 | Acquired |
| July 8, 2024 | RYTM | Stock Option (right to buy) | Common Stock (53,333) | $43.76 | July 7, 2034 | 53,333 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
RYTM
Chief Scientific Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $505,385 | — | — | — | $287,000 | — | $14,000 | $4,427,024 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.